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Abstract 1 
An experiment was conducted to assess the response of juvenile barramundi (Lates 2 
calcarifer) to four diets containing either marine- or non-marine derived neutral lipid (NL) or 3 
polar lipid (PL) sources for eight weeks in a 2x2 factorial design. The four diets contained 4 
8.2% added lipid composed of a 1% fish oil base with 7.2 % test lipid (n-3 NL: Fish oil, n-3 5 
PL: Krill oil, n-6 NL: Soybean oil, n-6 PL: Soybean lecithin). The results demonstrated that 6 
the different lipid sources (either n-3 or n-6 omega series from either NL or PL class) had 7 
significant effects on growth performance and feed utilisation with some interaction terms 8 
noted. Growth was negatively affected in the n-6 NL fish and the feed conversion (FCR) was 9 
highest in the n-6 PL fish. Digestibility of total lipid and some specific fatty acids (notably 10 
18:2n-6 and 18:3n-3) were also negatively affected in the n-6 PL fish. Analysis of the whole 11 
body neutral lipid fatty acid composition showed that these mirrored those of the diets and 12 
significant interaction terms were noted. However the whole body polar lipid fatty acids 13 
appeared to be more tightly regulated in comparison. The blood plasma biochemistry and 14 
hepatic transcription of several fatty acid metabolism genes in the n-6 PL fed and to a lesser 15 
extent in the n-6 NL fed fish demonstrated a pattern consistent with modified metabolic 16 
function. These results support that there are potential advantages in using phospholipid-rich 17 
oils however there are clear differences in terms of their origin. 18 
  19 
1 Introduction 1 
The phospholipids form the structural bilayer of cell membranes providing integrity and 2 
fluidity (Hazel and Williams, 1990; Tocher et al., 2008). Central to their biological 3 
importance is their structure with lipoproteins that assist in the extracellular transport of lipids 4 
thus improving parameters such as growth, survival and health throughout the organism 5 
(Tocher et al., 2008). However, the total lipid content in fish is mostly composed of neutral 6 
lipid in the form of triacylglycerol (TAG) which is a more readily available energy source 7 
(Glencross, 2009). 8 
There is evidence to suggest that most larval and early juvenile fish have a dietary 9 
requirement for intact phospholipids as endogenous biosynthesis is not sufficient (Coutteau et 10 
al., 1997). Coutteau et al. (1997) reported that the phospholipid requirement of fish and 11 
crustaceans varied depending on the life stage and history. Freshwater fish generally have 12 
lower dietary requirements, of around 2% whereas marine fish generally had higher 13 
requirement ranging up to 7% however that gradually reduced as fish grew. Early studies 14 
found that in both rainbow trout (Oncorhynchus mykiss) and Atlantic salmon (Salmo salar) 15 
the phospholipid requirement of first swim-up sized fish (<0.2 g) was 4% supplied in the 16 
form of soybean lecithin (Poston, 1990a; b). However, larger salmon (~7.5 g initial) showed 17 
no improvement in terms of growth suggesting that endogenous synthesis of phospholipid is 18 
sufficient to support the requirement of the fish and that high dietary levels had a negative 19 
effect on survival (Poston, 1990a). It should also be noted that the latter study, and possibly 20 
others, refer to a requirement of phospholipid containing ingredients rather than the precise 21 
phospholipid content which is often unclear.  22 
With very few exceptions, provision of marine derived phospholipid to cultured fish 23 
is limited. Moreover, there are few studies on the effect of dietary phospholipids in juvenile 24 
fish greater than 5 g as it is generally accepted that they don’t have a requirement based on 25 
the historical evidence presented for Atlantic salmon (Poston, 1990a). Recently, the influence 26 
of dietary phospholipid from either krill oil or soybean lecithin was investigated in Atlantic 27 
salmon from first feeding up to smolt (0 to 70 g range) (Taylor et al., 2015). These authors 28 
demonstrated a range of improvements among the parameters tested and concluded that 29 
Atlantic salmon have a dietary requirement for intact phospholipid particularly in early 30 
development. Therefore, with the continual reduction of fish meal (FM) and fish oil (FO) in 31 
commercial feeds and the complex biochemistry of the phospholipids particularly in juvenile 32 
fish, further investigation is warranted. Moreover, the preferential incorporation and retention 1 
of phospholipid fatty acids are important in maintaining phospholipid quality and also to 2 
fulfil other downstream roles of the phospholipid classes (Linares and Henderson, 1991).  3 
Recent in- and ex-vivo methods have so far demonstrated that barramundi or Asian 4 
seabass (Lates calcarifer) are not capable of any measureable long-chain polyunsaturated 5 
fatty acid (LC-PUFA) biosynthesis (Alhazzaa et al., 2011a; Mohd-Yusof et al., 2010; Tu et 6 
al., 2012). However, some notable effects on the phospholipid composition of tissues were 7 
identified, which may suggest that juvenile barramundi have a requirement for intact 8 
phospholipids in order to prevent the onset of deficiency (Alhazzaa et al., 2011b; Tu et al., 9 
2013). It appears that when dietary PL are not sufficient then very selective retention of tissue 10 
phospholipids occurs in barramundi and other species, until depletion, this being a 11 
mechanism to prevent the onset of PL deficiency and secondary pathologies as a result (Skalli 12 
and Robin, 2004; Tocher et al., 2008; Tu et al., 2013).  13 
Most phospholipid requirement studies to date have used soybean lecithin containing 14 
high levels of n-6 PUFA, while others have used egg lecithin or various other marine sources 15 
such as fish roe lecithin (Cahu et al., 2009). Recent studies have clearly demonstrated the 16 
potential of marine derived phospholipid sources to improve larval and juvenile fish 17 
performance (Betancor et al., 2012; Taylor et al., 2015). To date, information is scarce on the 18 
effect phospholipid in juvenile barramundi diets. Therefore, an experiment was designed to 19 
compare the metabolic effect of marine and non-marine neutral lipid (NL) and polar 20 
phospholipid (PL) sources using a two-by-two factorial approach in juvenile barramundi. The 21 
biochemical and molecular mechanisms underpinning the role of phospholipids was also 22 
investigated.  23 
2 Materials and methods 24 
2.1. Ingredient and diet preparation 25 
The diets were formulated to provide digestible protein at ~55 %, lipid at ~12 % with a 26 
digestible energy value of ~19 MJ/kg. The dry ingredients were passed separately through a 27 
hammermill (Mikro Pulverizer, type 1 SH, New Jersey, USA) such that the maximum 28 
particle size was less than 750 µm. All ingredients were then thoroughly mixed in using an 29 
upright commercial mixer (Bakermix, Model 60 A-G, NSW, Australia). The chemical 30 
composition of the main dietary ingredients is presented in Table 1. A single batch of basal 31 
diet was prepared then divided up and warmed aliquots of the oil mixtures were thoroughly 1 
mixed in. Water was added at approximately 30% of the mash weight and then mixed until 2 
consistent dough was formed. The pellets were extruded through a 4mm die attached to a 3 
screw-press pasta machine and cut off at lengths of 5 to 6mm. The pellets were dried 4 
overnight at 60˚C to a constant dry matter and stored in a freezer until required. The 5 
formulation and chemical composition of the four diets are presented in Table 2. 6 
2.2. Barramundi husbandry and growth 7 
Juvenile barramundi (Lates calcarifer) were sourced from the Betta Barra fish hatchery 8 
(Atherton, QLD, Australia), on-grown in a 10,000L tank and fed a commercial diet (Marine 9 
Float; Ridley Aquafeed, Narangba, QLD, Australia). Prior to commencement of the 10 
experiment the fish were transferred to a series of experimental tanks (300L) with flow-11 
through seawater (salinity =35 PSU; dissolved oxygen 4.6 ± 0.15 mg /L) maintained at 30.0 ± 12 
0.01 ºC (mean ± SD) with a supply rate of about 3 L/min to each of the tanks. The tanks were 13 
maintained in an environment-controlled laboratory with the photoperiod set to a constant 14 
12:12h cycle. At the beginning of the experiment, the tanks held 26 fish of 47.0 ± 0.3 g (mean 15 
± SD, n =312 individually weighed fish). The four experimental diets were randomly 16 
distributed amongst the twelve tanks with each treatment having three replicate tanks. The 17 
fish were offered their respective diets to apparent satiety once daily except on the day of 18 
sampling. 19 
2.3. Sample collection, preparation and digestibility analysis 20 
Ethical clearance was approved for the experimental procedures by the CSIRO animal ethics 21 
committee A11/2013. Six fish of similar size from the original stock were euthanized by an 22 
overdose of AQUI-S™ (Lower Hutt, New Zealand) at the beginning of the experiment and 23 
stored at -20 ºC until analysis. A further six fish were dissected and whole blood was 24 
removed from the caudal vein using 1 mL pre-heparinised syringes and an 18 G needle. 25 
Blood was pooled in a single Vacutainer™ tube and then centrifuged at 10,000 rpm for 5 min 26 
to settle the erythrocytes. The plasma was then drawn off and transferred to a 1.5 mL 27 
Eppendorf™ tube and frozen before being sent for analysis. A sample of liver tissue was then 28 
removed and placed into 1.5 mL screw-top vial and kept on dry ice before being transferred 29 
to a -80 ˚C freezer until analysis. The same sampling procedure occurred after 56 d with three 30 
fish from each treatment while the remaining fish were returned to their respective tank after 31 
a short recovery.  All sampling procedures occurred 24 h after the last feeding event (Wade et 1 
al., 2014). 2 
Prior to the termination of the growth assay, faeces were collected using established 3 
settlement protocols (Blyth et al., 2014; Glencross et al., 2005). Briefly, a collection chamber 4 
was filled with water and frozen then attached to the evacuation line of a swirl separator and 5 
left overnight. The following morning, the collection chamber was removed and the chilled 6 
faeces were captured in a plastic sample container and stored at -20 ˚C until analysis.  7 
2.5. Chemical analysis 8 
Prior to analysis the diets were each ground to a fine powder using a bench grinder 9 
(KnifeTec™ 1095, FOSS, Denmark). The whole fish were passed through a commercial meat 10 
mincer (MGT – 012, Taiwan) twice to obtain a homogeneous mixture. A sample was taken 11 
for dry matter analysis and another sample was freeze-dried along with the faecal samples 12 
until no further loss of moisture was observed (Alpha 1-4, Martin Christ, Germany). Dry 13 
matter was calculated by gravimetric analysis following oven drying at 105ºC for 24 h. Total 14 
yttrium concentrations were determined after nitric acid digestion in a laboratory microwave 15 
digester (Ethos One, Milestone, Italy) using inductively coupled plasma mass 16 
spectrophotometry (ICP-MS) (ELAN DRC II, Perkin Elmer, USA). Crude protein was 17 
calculated after the determination of total nitrogen by organic elemental analysis (CHNS-O, 18 
Flash 2000, Thermo Scientific, USA), based on N x 6.25. Total lipid content was determined 19 
gravimetrically following extraction of the lipids using chloroform:methanol (2:1) following 20 
Folch et al. (1957). Gross ash content was determined gravimetrically following loss of mass 21 
after combustion of a sample in a muffle furnace at 550˚C for 12 h. Gross energy was 22 
determined by adiabatic bomb calorimetry (Parr 6200 Calorimeter, USA). Differences in the 23 
ratio of dry matter, protein, lipid and energy to yttrium in the diet and faeces were calculated 24 
to determine the apparent digestibility coefficients (ADC) using the formula: 25 
𝐴𝐷𝐶 =  (1 − (
𝑌𝑑𝑖𝑒𝑡 ×𝑃𝑎𝑟𝑎𝑚𝑒𝑡𝑒𝑟𝑓𝑎𝑒𝑐𝑒𝑠
𝑌𝑓𝑎𝑒𝑐𝑒𝑠 ×𝑃𝑎𝑟𝑎𝑚𝑒𝑡𝑒𝑟𝑑𝑖𝑒𝑡
)) ×100 26 
Where Y diet and Y faeces represent the yttrium content in both the diet and faeces, respectively 27 
and Parameter diet and Parameter faeces represent the nutritional parameter (dry matter, protein, 28 
lipid and energy) in the diet and faeces, respectively (Glencross et al., 2007).  29 
Plasma samples were sent to the West Australian Animal Health Laboratories (South Perth, 1 
Western Australia) for enzyme and chemistry assessment. The assays were run on an 2 
Olympus AU400 automated chemistry analyser (Olympus Optical Co. Ltd). Each of the 3 
assays used was a standard kit developed for the auto-analyser. The tests performed included 4 
alanine aminotransferase (ALT, EC 2.6.1.2) (Olympus kit Cat. No. OSR6107), creatine 5 
kinase (CK, EC 2.7.3.2) (Olympus kit Cat. No. OSR6179), glutamate dehydrogenase 6 
(GLDH, EC 1.4.1.2) (Randox kit Cat. No. GL441), total protein (Olympus kit Cat. No. 7 
OSR6132), creatinine (Olympus kit Cat. No. OSR6178), alkaline phosphatase (Olympus kit 8 
Cat. No. OSR6004), glucose (Olympus kit Cat. No. OSR6121), haemoglobin (Randox kit 9 
Cat. No. HG1539) and haptoglobin (Randox kit Cat. No. HP3886). Trace elements were 10 
determined after mixed acid digestion using inductively coupled plasma mass spectrometry 11 
(ICP-MS). 12 
Fatty acid composition was determined following the methods of Christie (2003). Lipids 13 
were esterified by an acid-catalysed methylation and 0.3 mg of an internal standard was 14 
added to each sample (21:0 Supelco, PA, USA). The fatty acids were identified relative to the 15 
internal standard following separation by gas chromatography (GC). An Agilent 16 
Technologies 6890N GC system (Agilent Technologies, California, USA) fitted with a DB-17 
23 (60m x 0.25mm x 0.15 μm, cat 122-2361 Agilent Technologies, California) capillary 18 
column and flame ionisation detection was used. The temperature program was 50–175 ºC at 19 
25 ºC /min then 175–230 ºC at 2.5 ºC /min. The injector and detector temperatures were set at 20 
250 ºC and 320 ºC, respectively. The column head pressure was set to constant pressure mode 21 
at 170 kPa using hydrogen as the carrier gas. The peaks were identified by comparing 22 
retention times to the internal standard and further referenced against known standards (37 23 
Comp. FAME mix, Supelco, PA, USA). The resulting peaks were then corrected by the 24 
theoretical relative FID response factors (Ackman, 2002) and quantified relative to the 25 
internal standard. 26 
Lipid extracts were applied to silica Sep-Pak® (Waters, Massachusetts, USA) columns and 27 
separated into neutral (non-phosphorus) lipid and polar (phosphorus) lipid following Juaneda 28 
and Rocquelin (1985). Briefly, Sep-Pak® columns were pre-conditioned with 4ml of hexane 29 
before a 30 mg sample of lipid dissolved in chloroform was applied to each column. The 30 
neutral lipid was first eluted with 20 ml of chloroform and followed by 5 ml of 31 
chloroform:methanol (49:1). The polar lipid was then eluted with 30 ml of methanol. The 32 
proportion of either neutral or polar lipid was quantified gravimetrically and then an aliquot 1 
was further esterified and separated into fatty acids following the protocol above.   2 
2.6. Mass balance calculations 3 
Nutrient retention efficiencies were calculated as the ratio of the nutrient or specific fatty acid 4 
gained relative to their respective consumption during the study period using the formula:  5 
𝑅𝑒𝑡𝑒𝑛𝑡𝑖𝑜𝑛 (%) = (
𝑁𝑓 − 𝑁𝑖
𝑁𝑐
) ×100 6 
Where Nf and Ni are the final and initial nutrient composition (g/fish) of the fish on a wet 7 
basis, respectively, and Nc is the amount of the nutrient consumed (g/fish) during the study 8 
period (Maynard and Loosli, 1979). The computation of apparent in vivo fatty acid 9 
elongation, desaturation and β-oxidation was performed using the whole-body fatty acid 10 
balance method (WBFABM) following Turchini et al. (2007). Briefly, this involved 11 
determination of the appearance/disappearance of specific fatty acids by mass balance. The 12 
resulting values of net appearance/disappearance were then transformed to a molecular 13 
weight basis per gram of body weight per day (nmol/g fish/d). Subsequent back calculations 14 
along the known fatty acid bioconversion pathways were used to determine the fate of 15 
specific fatty acids. 16 
2.7. RNA extraction and normalisation 17 
Total RNA was extracted using Trizol reagent (Invitrogen) according to the manufacturer’s 18 
instructions. RNA was precipitated using equal volumes of precipitation solution (1.2 M 19 
sodium chloride and 0.8 M disodium citrate) and isopropyl alcohol (Green and Sambrook, 20 
2012). To eliminate any residual traces of DNA, total RNA was DNase digested with the 21 
Turbo DNA free kit (Applied Biosystems). To verify that RNA was not contaminated, an 22 
aliquot of DNase digested RNA from each sample was pooled (n=32) and later PCR 23 
amplified as a negative control. A NanoDrop spectrophotometer (NanoDrop Technologies) 24 
was used to asses RNA quantity and a Bioanalyser (Agilent Technologies) using RNA 25 
nanochips (Agilent #5067-1511) was used to asses RNA quality. All RNA samples were 26 
normalised to 200 ng/µl. 27 
2.8. Quantitative real time RT-PCR 28 
Expression of a range of genes involved in fatty acid metabolism was analysed by real-time 1 
qPCR as described below (Table 4). Of the genes examined in the present study, fatty acid 2 
elongation 5, fatty acid desaturation 6 and elongation factor 1α (GQ214180.1, GQ214179.1, 3 
GU188685) are contained within the published nucleotide database. The remaining genes 4 
were previously identified and reported following next generation sequencing of barramundi 5 
liver tissue and BLAST similarity searches (Wade et al., 2014). The raw sequence read data 6 
are made available online through the CSIRO Data Access Portal 7 
(http://doi.org/10.4225/08/55E799BA0F73E). For cDNA synthesis, 1 µg of total RNA was 8 
reverse transcribed using superscript III (Invitrogen) with 25 µM oligo (dT)20 and 25 µM 9 
random hexamers (Resuehr and Spiess, 2003). Real-time PCR amplification reactions were 10 
carried out using 1X SYBR Green PCR Master Mix (Applied Biosystems), 0.2 µM of Real-11 
Time PCR primers specific to each gene and the equivalent of 7.5 ng of reverse-transcribed 12 
RNA. Amplification cycle conditions were 2 min at 50 ˚C, 10 min at 95 ˚C followed by 40 13 
cycles of 15 s at 95 ˚C and 40 s at 60 ˚C. After amplification, a melt curve analysis was 14 
routinely performed to verify the specificity of the target gene. Reactions were setup using 15 
the epMotion 5070 robot (Eppendorf) and run in triplicate on a Viia7 real-time PCR system 16 
(Applied Biosystems). Changes in expression levels of each gene were determined by 17 
normalising the cycle threshold values for each gene to elongation factor 1 alpha (EF1α) and 18 
Luciferase (Luc) reference genes, then to the cycle threshold of each gene in the initial fish 19 
samples. The variation in amplification of EF1α was 1.24 cycles and Luc was 0.58 cycles and 20 
this did not significantly change over time. The EF1α and Luc genes are routinely used as a 21 
reference in this species (De Santis et al., 2011; Wade et al., 2014). 22 
2.9. Statistical analysis 23 
All data are expressed as mean ± SEM unless otherwise specified. All data were checked for 24 
normal distribution and homogeneity of variance by qualitative assessment of residual and 25 
normal Q-Q plots. All data were analysed by two-way factorial ANOVA using the RStudio 26 
package v.0.98.501 (R Core Team, 2012). Any variables with only three treatments of data 27 
were analysed by one-way ANOVA. Any percentage data were arcsine transformed prior to 28 
analysis. Levels of significance were compared using Tukey’s HSD a posteriori test with 29 
significance among treatments defined as P < 0.05.  30 
3 Results 31 
3.1 Growth and feed utilisation 1 
In the present study the two levels of omega status were defined as n-3 and n-6 and the two 2 
levels of lipid class were defined as neutral lipid and phospholipid. There was no difference 3 
in the initial weight of the fish among the treatments; however there were significant 4 
differences in the growth and feed utilisation parameters (as final weight, feed intake and 5 
FCR) upon termination of the 56 d growth assay (Table 5). There were significant interaction 6 
terms indicating that the effectiveness of phospholipid-rich ingredients was found to be 7 
dependent on the omega status for the final weight, feed intake and FCR. The lowest growth 8 
performance was seen in the fish fed n-6 NL (soybean oil) and the FCR was reduced in the n-9 
6 PL fed fish (soybean lecithin). There were no differences in terms of survival with only 10 
three fish removed from the system. There were no significant differences in either protein or 11 
lipid retention (Table 5). 12 
There were no differences in apparent digestibility of dry matter, protein or gross energy 13 
(Table 6). There was a significant interaction effect indicating that the digestibility of total 14 
lipid in the phospholipid-rich treatments was dependent on the omega status with the lowest 15 
lipid digestibility in the n-6 PL (soybean lecithin) treatment. There was a significant 16 
interaction in the digestibility of 16:0 which showed that the highest digestibility in the n-6 17 
NL treatment was dependent on the lipid class. There was also a significant interaction noted 18 
for the digestibility of 18:2n-6, total C18PUFA and total n-6 showing that the digestibility of 19 
fatty acids from phospholipid-rich ingredients was dependent on the omega status. In each 20 
case the digestibility was lowest in the n-6 PL treatment (soybean lecithin). Similarly, the 21 
digestibility of 18:3n-3 was significantly lower in the n-6 PL fed fish. 22 
3.2 Biochemical analysis 23 
As intended, the neutral and polar composition of the diets was reflective of the lipid 24 
composition of the ingredients used (Table 3).There were no significant differences in the 25 
neutral and polar composition of the whole fish with all treatments in the range of 89.4 to 26 
94.0 % neutral lipid (Table 7). Fatty acid analysis of the neutral and polar fractions revealed 27 
several significant differences among the treatments. Significant interaction terms were noted 28 
for many of the neutral lipid fatty acids. Most notably, the effect of phospholipid-rich 29 
ingredients on LC-PUFA (specifically 22:6n-3, 22:5n-3 and 20:5n-3) composition in the 30 
whole fish were found to be dependent on the omega status with the highest levels present in 31 
the n-3 treatments. Of the polar lipid fatty acids, the18:2n-6 composition was significantly 1 
higher in the n-6 treatments whereas the 16:0, 20:5n-3 and 22:6n-3 composition was highest 2 
in the n-3 treatments. 3 
There was several significant interaction terms noted on the apparent in-vivo β-oxidation 4 
activity (Table 8). The phospholipid-rich ingredients were found to be effective in modifying 5 
the β-oxidation of MUFA in the n-6 PL fed fish however this was not the case for the n-3 PL 6 
fish. There was a significant interaction term noted in the β-oxidation C18PUFA and Total n-6 7 
with the highest activity in the phospholipid-rich lipid being dependent on the omega status. 8 
There was also a significant interaction for the β-oxidation of LC-PUFA and Total n-3 which 9 
was dependent on the omega status with the highest activity in the n-3 NL treatments.   10 
There was a significant interaction indicating that elongation activity of SFA was highest in 11 
the n-6 NL treatment and lowest activity was in the n-3 NL treatment (Table 8). There was no 12 
detectable elongation activity of the LC-PUFA or Total n-3 in the n-3 NL fed fish; however, 13 
when analysed by one-way ANOVA there was significantly greater activity in the n-3 PL fed 14 
fish compared to both of the n-6 treatments. There was also a significant interaction in the 15 
delta-9 (SCD) desaturation activity with greatest activity recorded in the n-6 NL and the 16 
lowest activity in the n-3 NL treatment.  17 
There was a significant interaction in the plasma GLDH enzyme with an elevated level 18 
present in the n-6 PL treatment which was dependant on the omega status (Table 9). 19 
Similarly, there was a significant interaction noted on plasma creatinine levels with an 20 
elevated level in the n-6 PL fish which was dependent on the omega status. The plasma 21 
cholesterol level was significantly elevated in the n-3 PL treatment and lowest in the n-6 NL 22 
and n-6 PL treatments. Circulating protein levels in the plasma were also significantly higher 23 
in the phospholipid class treatments. Among the haematological parameters, only minor 24 
numerical differences were observed with Hb significantly elevated in the n-3 NL fish and 25 
haptoglobin significantly elevated in the n-6 PL fish (Table 9). 26 
3.3 Gene expression 27 
Several significant differences were observed in the expression of genes related to fatty acid 28 
metabolism (Figure 1). There was a significant interaction in the relative gene expression of 29 
Lc ACYL, Lc FAS and Lc FADS2 with increased expression in the n-6 PL treatment that was 30 
dependent on the lipid class. The expression of these genes was at least 1.5-fold higher in the 1 
n-6 PL compared to the n-3 PL treatments. There was also a significant interaction effect in 2 
the modification of Lc CPT1α expression by the phospholipid-rich ingredients was dependent 3 
on the omega status. The expression of Lc CPT1α was down regulated by approximately 1.5-4 
fold in the n-3 PL compared to the control. Similarly, the expression of Lc SCD was 5 
significantly up regulated in the n-6 treatments compared to the n-3 treatments however there 6 
was no interaction effect observed. The expression of Lc ELOVL5 in all treatments was down 7 
regulated compared to the initial fish levels however there were no significant differences 8 
among the treatments. 9 
4 Discussion 10 
It is well established that larval and early juvenile fish have a dietary requirement for intact 11 
phospholipids that can lead to long term improvements in many growth performance 12 
parameters (Coutteau et al., 1997; Tocher et al., 2008). Historically most phospholipid studies 13 
were conducted with commercial phospholipid preparations of commonly available 14 
emulsifying agents such as lecithin from soybeans or corn (Tocher et al., 2008). However, in 15 
some cases the use of these products has potentially lead to unclear requirement data as the 16 
composition of polar lipid and polar lipid classes is seldom reported and there are other 17 
potential interacting effects of the ingredients themselves. The aims of the present study were 18 
to provide an up to date assessment of the physiological and metabolic effect of commercially 19 
available preparations of phospholipid-rich ingredients such as krill oil and soybean lecithin 20 
against neutral lipid-rich ingredients such as fish oil and soybean oil in juvenile barramundi. 21 
Based on the performance data of the present study, it is clear that for barramundi in the 22 
range of ~47 to ~238 g, that a response to the lipid ingredients was evident. It should be noted 23 
that each of the diets were prepared with a minimum (1% diet) inclusion of FO in order to 24 
prevent the onset of essential fatty acid deficiency (Salini et al., 2015). The growth, feed 25 
intake and FCR of the n-3 NL and n-3 PL fed fish were nearly identical. Despite the n-6 PL 26 
fed fish being statistically the same weight as the two n-3 diets they consumed significantly 27 
more feed which resulted in a higher FCR. Many studies have clearly demonstrated that 28 
growth potential is driven by the demand for energy (derived mostly from protein and lipid) 29 
in this species (Glencross et al., 2013). However, the diets in the present study were 30 
equivalent in digestible energy and the n-6 PL fish consumed more feed to maintain growth, 31 
comparable to the control (n-3 NL) fish suggesting that the difference in FCR is attributable 1 
to the lipid ingredients. Therefore this suggests that the lecithin was poorly utilised by the fish 2 
as also supported by numerically lower lipid retention in this treatment. There may be other 3 
features of the soybean lecithin that contributed to the results observed however investigation 4 
of these was beyond the objectives of the present study. 5 
A recent study on dietary phospholipids in Atlantic salmon over a range of sizes (from first 6 
feeding to ~60 g) found that at 2.6% phospholipid in the form of soybean lecithin reduced 7 
growth performance and FCR (Taylor et al., 2015). However the most profound negative 8 
effect of soybean lecithin on growth rate (SGR) was in early phase (first feeding to 2.5 g) 9 
rather than the latter stages of growth studied. It should be clearly noted that the diets used in 10 
the present study included 7.2 % added lipid to a base of 1% fish oil. Based on the analysed 11 
composition of the diets used in the present study, the determined level of phospholipid in the 12 
lecithin diet was around 5.8 % and the krill diet was around 4.0%. It is unclear whether this 13 
level of inclusion could have influenced the growth performance of the n-6 PL fed fish. In the 14 
study of Taylor et al. (2015), the inclusion of krill oil above 2.6% phospholipid led to a 15 
decrease in the growth of Atlantic salmon however no effect of krill oil was seen in the 16 
present study. They reasoned that the difference could be due to the reduced energy 17 
availability of phospholipid-rich oils compared to that of neutral lipid oils that are mostly 18 
triacylglycerol (Taylor et al., 2015).  19 
In larval fish, the digestibility of diets containing phospholipids is consistently better than 20 
control diets, mostly owing to their emulsifying effect leading to better absorption by the 21 
developing gut system (Coutteau et al., 1997; Tocher et al., 2008). In contrast, the juvenile 22 
barramundi fed soybean lecithin in the present study had the lowest total lipid digestibility 23 
potentially owing to its physical characteristics rather than its chemical composition. 24 
However, the most abundant fatty acid in the phospholipid fraction of the n-6 PL diet was 25 
18:2n-6 and this was also significantly less digestible leading to the lowest total C18PUFA 26 
digestibility. These reductions in digestibility most likely also led to the poor FCR observed 27 
in that treatment group. However it is unclear whether these effects are caused by the 28 
phospholipid composition or another feature of the ingredient as the same effects were not 29 
replicated in the krill oil fed fish.   30 
A further interesting result of the present study was that the n-6 NL fed fish ate less and 31 
consequently grew less than the n-3 treatments with no difference in FCR. The digestibility 32 
was also high for the total lipid and all the dominant fatty acids in fish fed the n-6 NL diet. 1 
This reduction in growth might be explained by several mechanisms. Firstly, soybean oil 2 
lacks any measureable n-3 LC-PUFA and to some extent is also likely to be pro-3 
inflammatory due to the high proportion of omega-6 fatty acids (Brown and Hart, 2011; 4 
Turchini et al., 2009). However, the reduced growth response should also have been expected 5 
in the n-6 PL fed fish as the fatty acid composition of the raw ingredients is quite similar.  6 
Of all the studies investigating the use of soybean oil, growth reduction is rarely reported in 7 
fish (Brown and Hart, 2011; Glencross, 2009). In a study by Raso and Anderson (2003) they 8 
found that although juvenile barramundi fed soybean oil grew slightly less than the controls it 9 
was not confirmed statistically and the FCR also remained unchanged. However, in a select 10 
group of marine species, such as the black sea bream (Acanthopagrus schlegeli), Japanese 11 
flounder (Paralichthys olivaceous), red sea bream (Pagrus auratus), silver bream 12 
(Rhabdosargus sarba) and cobia (Rachycentron canadum) feeding exclusively with soybean 13 
oil has lead to differences in growth performance, however most simply put, they were 14 
probably caused by essential fatty acid (EFA) deficiency rather than another unique feature of 15 
the soybean oil itself (Brown and Hart, 2011; Trushenski et al., 2012).   16 
Another more recent hypothesis is that certain fatty acids including 18:2n-6 may influence 17 
feed intake by modulating the expression of ‘satiety’ and ‘hunger’ hormones via various 18 
signalling pathways, for example neuropeptide Y or Agouti-related protein (NPY and AGRP 19 
respectively), however, this is yet to be thoroughly explored in teleost fish (Coccia et al., 20 
2014; Liland et al., 2013; Schwartz et al., 2000). Therefore, in light of the many possibilities, 21 
the fish fed the n-6 NL (soybean oil) diet in the present study were likely to be EFA deficient. 22 
However, the same effect did not manifest itself in the n-6 PL fish, indicating a marginal 23 
improvement owing to the phospholipid content of the diet. 24 
In the present study, the whole body fatty acid composition mostly resembled the diet profiles 25 
as previously reported in the vast majority of studies (Rosenlund et al., 2011). Despite the 26 
varied NL and PL composition of the diets used in the present study, it was clear that the 27 
proportion of NL and PL in the whole body was tightly regulated. However there were some 28 
changes to the fatty acid composition of both the NL and PL fraction of the whole body, 29 
consistent with other studies. In larval fish such as sea bream, increasing marine derived PL 30 
led to better assimilation of n-3 FA whereas soybean lecithin PL increased assimilation of n-6 31 
FA (Saleh et al., 2015). Alhazzaa et al. (2011b) correlated the up regulation of fatty acid 32 
synthesis genes (FADS2 and ELOVL5) with highly selective fatty acid retention in muscle 1 
and liver PL composition of juvenile barramundi fed vegetable oils. Other studies have also 2 
demonstrated that the LC-PUFA composition of the PL fraction of certain tissues is tightly 3 
regulated in the absence of adequate dietary supply (Skalli et al., 2006). In the present study, 4 
this effect was seen with the n-6 NL (soybean oil) fish able to retain numerically more n-3 5 
LC-PUFA than the n-6 PL fish. Moreover, 18:2n-6 was preferentially retained in the n-6 NL 6 
fed fish.  7 
In the present study, the apparent in vivo whole body mass-balance of specific fatty acids was 8 
calculated to determine discrete differences in metabolism (Turchini et al., 2007). The LC-9 
PUFA β-oxidation activity was highest in the n-3 NL followed by the n-3 PL fish, typical of 10 
when barramundi and other species are fed excess LC-PUFA (Salini et al., 2015; Stubhaug et 11 
al., 2007).  The high elongation of SFA and delta-9 desaturation activity in the n-6 NL fish 12 
suggests an attempt to generate 18:1n-9 as an available energy source. However, there was no 13 
corresponding increase in β-oxidation of MUFA and moreover the same effect was not 14 
recorded in the n-6 PL fish.  It is unclear as to why they would invest energy into elongation 15 
and delta-9 desaturation processes with no further downstream effect; however, it clearly 16 
indicates a modified metabolic function that could be part of a compensatory mechanism 17 
when EFA deficient. Moreover, it is difficult to correlate the mass-balance computations with 18 
the quantitative gene expression analysis used in the present study as different enzymes are 19 
involved throughout the fatty acid metabolic pathway. However, the mass-balance results do 20 
correlate with those previously reported in barramundi and other species fed alternative oils 21 
(Francis et al., 2007; Salini et al., 2015; Turchini et al., 2013). 22 
The biochemical analysis of the plasma and the hepatic gene expression potentially indicate a 23 
modified metabolic pattern, particularly as a result of the n-6 lipids, soybean lecithin and to a 24 
lesser extent soybean oil. However, there were no dramatic sub-clinical pathologies noted 25 
indicating the potential relevance of these ingredients. Creatinine kinase (CK) levels were 26 
however numerically highest in the n-3 NL fed fish and although there is a general lack of 27 
data in this and other teleost species it could be argued that these fish were in a diseased state 28 
(Nanji, 1983; Sandnes et al., 1988). However, it may also be reasoned that these are the 29 
normal enzyme levels as they are the control group of this study. The elevated glutamate 30 
dehydrogenase (GLDH) activity, creatinine level and total protein in the plasma of the n-6 PL 31 
fish are potentially indicative of organ failure or dehydration that can be characterised by the 32 
depletion of hepatic LC-PUFA stores (Van Waes and Lieber, 1977; Videla et al., 2004). 1 
However, the plasma enzyme markers (eg GLDH and ALT) are typically used in 2 
combination to confirm a clinical diagnosis and in the present study there is not adequate 3 
evidence to support this. In contrast, none of the plasma markers were elevated in the n-6 NL 4 
fed fish. In addition, several authors have reasoned that together elevated GLDH and plasma 5 
urea are implicated in osmoregulatory processes leading to clinical pathologies such as 6 
subcutaneous haemorrhaging (Glencross and Rutherford, 2011; Morton et al., 2014). 7 
However, in the present study these pathologies were not present and moreover the plasma 8 
urea content was unaffected suggesting that the lipid sources used were nutritionally adequate 9 
unlike those of the previously mentioned studies. Further work is clearly warranted in this 10 
area to resolve some of the discrepancies relating to clinical diagnosis in barramundi and 11 
other teleosts.  12 
The hepatic expression of genes related to fatty acid initial synthesis (Lc ACYL and Lc FAS) 13 
and delta-6 and delta-9 desaturation (Lc FADS2 and Lc SCD), were also significantly up 14 
regulated in n-6 PL fed fish. These transcriptional changes suggest that there was potentially 15 
a metabolic modification liver and the fish have a limited ability to respond to the soybean 16 
lecithin. Recent studies have shown similar nutritional regulation of fatty acid metabolism 17 
related genes with soybean oil (Li et al., 2016); however the same effect of soybean oil (diet 18 
n-6 NL) was not replicated to the same extent in the present study. Interestingly, the 19 
expression of Lc CPT1α, which is considered to be the initial step in the mitochondrial β-20 
oxidation of fatty acids, was dependent on the omega status being significantly down 21 
regulated in the n-3 PL fish compared to the n-3 NL fish (Frøyland et al., 1998). Moreover, 22 
the apparent in vivo β-oxidation of SFA, MUFA and PUFA was also significantly lower in 23 
the n-3 PL treatment which may indicate an active anti-oxidant effect of phospholipid rich 24 
lipids of marine origin such as krill (Saito and Ishihara, 1997).  25 
5 Conclusions 26 
Studies have consistently demonstrated a range of advantages when using phospholipid-rich 27 
lipid sources in diets for larval and juvenile fish. In this study, we report for the first time the 28 
use of phospholipid-rich krill oil and also soybean lecithin compared to neutral lipid sources 29 
including fish oil and soybean oil. In support of the vast majority of studies, we demonstrated 30 
that the inclusion of either marine or non-marine phospholipid maintains performance of 31 
juvenile barramundi equivalent to a fish oil based control diet. An interesting result of the 1 
present study was the differences observed between both the n-6 diets. The fish fed soybean 2 
lecithin avoided gross signs on EFA deficiency which was in contrast to the soybean oil fed 3 
fish. However, the dietary soybean lecithin affected the FCR and some sub-clinical markers 4 
potentially indicated a modified metabolic function.  5 
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Figure 1. Hepatic gene expression of selected lipid metabolism genes in juvenile barramundi (Lates 1 
calcarifer) after eight weeks of feeding. Relative expression is calculated for each gene using cycle 2 
threshold values, normalised to control genes (Elongation factor 1a and Luciferase). Values are shown 3 
as log-2 fold change relative to the initial fish. Letters above error bars indicate significant differences 4 
between the treatments. Analysed by two-way factorial ANOVA, df 1,1,1,8, post-hoc Tukey's HSD. 5 
  6 
Table 1 Chemical composition of ingredients used in experimental diets, all values are g/kg DM unless otherwise stated     
    
Fish 
meal# 
Poultry 
meal  
Soy 
isolate  
Wheat 
gluten 
Wheat 
flour Casein  
Wheat 
starch Fish oil  Krill oil 
Soybean 
oil 
Soybean 
lecithin 
Composition 
 
                    
  Dry matter (g/kg) 98.4 95.8 95.8 92.7 83.9 92.4 83.6 99.2 99.9 100.0 98.0 
  Protein 78.9 64.1 89.5 82.3 11.2 87.0 0.5 0.4 4.5 1.0 7.5 
  Ash 16.3 13.8 4.6 0.1 0.6 1.1 0.3 0.1 2.9 ND 9.8 
  Lipid 4.6 15.1 5.7 12.1 2.2 0.5 ND 95.6 92.6 94.6 75.7 
  Carbohydrate 0.1 7.0 0.2 5.5 86.0 11.3 99.2 3.9 ND 4.5 7.1 
  Gross energy (mJ/kg) 18.9 20.4 21.8 21.2 15.3 21.9 14.5 39.3 36.3 39.5 29.7 
Fatty acids (mg/g lipid)^ 
 
                    
 
16:0 149.0 161.7 NA NA NA NA NA 128.4 107.3 93.7 111.5 
  18:0 50.9 55.4 NA NA NA NA NA 29.0 6.3 35.4 23.7 
  18:1 89.8 277.0 NA NA NA NA NA 104.0 90.0 220.7 53.3 
  18:2n-6 10.4 71.4 NA NA NA NA NA 11.7 12.2 430.6 326.1 
  18:3n-3 4.7 7.1 NA NA NA NA NA 5.8 7.1 49.7 41.8 
  20:4n-6 16.4 4.5 NA NA NA NA NA 9.1 3.2 ND ND 
  20:5n-3 57.6 3.7 NA NA NA NA NA 70.3 144.5 ND ND 
  22:5n-3 13.0 ND NA NA NA NA NA 12.4 0.0 ND ND 
  22:6n-3 152.2 ND NA NA NA NA NA 105.3 94.8 ND ND 
  SFA 231.5 230.1 NA NA NA NA NA 205.5 175.3 137.1 135.8 
  MUFA 129.1 322.0 NA NA NA NA NA 163.2 135.5 221.7 53.3 
  C18PUFA 20.0 78.5 NA NA NA NA NA 27.5 39.6 483.6 367.9 
  LC-PUFA 244.4 8.2 NA NA NA NA NA 200.5 242.6 ND ND 
  Total n-3  222.7 3.7 NA NA NA NA NA 198.0 259.7 ND ND 
  Total n-6  36.7 83.0 NA NA NA NA NA 29.9 22.5 483.6 367.9 
# Fish meal was defatted using hexane. Please see methods for details. NA, Not analysed; ND, Not detected. 
^ 18:1, sum of 18:1n-7, 18:1n-9 cis, 18:1n-9 trans; saturated fatty acids (SFA), sum of 12:0, 14:0, 16:0, 18:0, 20:, 22:0, 24:0; monounsaturated fatty acids 
(MUFA), sum of 14:1n-5, 16:1n-7, 18:1n-7, 18:1n-9 (cis and trans), 20:1n-7, 20:1n-9, 22:1n-9, 24:1n-9; polyunsaturated fatty acids, with 18 carbon atoms 
(C18 PUFA), sum 18:2n-6 (cis and trans), 18:3n-6, 18:3n-3, 18:4n-3; long chain polyunsaturated fatty acids, with 20 or more carbon atoms (LC-PUFA), sum 
20:2n-6, 20:3n-6, 20:4n-6, 22:4n-6, 20:3n-3, 20:5n-3, 22:5n-3, 22:6n-3; n-3, sum of omega 3 C18 PUFA and LC-PUFA; n-6, sum of omega 6 C18 PUFA and 
LC-PUFA. 
Table 2 Formulation and composition (as analysed) of experimental diets, all values are g/kg unless 
otherwise stated 
  
n-3 NL 
(Fish) 
n-3 PL 
(Krill) 
n-6 NL 
(Soybean) 
n-6 PL 
(Lecithin) 
Formulation         
  Fish meal a 150 150 150 150 
  Poultry meal a 150 150 150 150 
  Soy protein isolate b 150 150 150 150 
  Wheat gluten b 150 150 150 150 
  Wheat flour b 109 109 109 109 
  Casein c 100 100 100 100 
  Pregelled wheat starch b 80 80 80 80 
  DL-Methionine 10 10 10 10 
  Di-calcium phosphate 10 10 10 10 
  Pre-mix vitamins d 8 8 8 8 
  Yttrium oxide e 1 1 1 1 
  Fish oil a 82 10 10 10 
  Krill Oil f 0 72 0 0 
  Soy oil g 0 0 72 0 
  Soy lecithin g 0 0 0 72 
Composition          
  Dry matter (g/kg) 940 933 959 952 
  Protein(g/kg DM) 598 613 597 593 
  Digestible protein (g/kg DM) 547 561 559 555 
  Ash (g/kg DM) 64 65 67 70 
  Lipid (g/kg DM) 122 124 122 118 
  Carbohydrate (g/kg DM)^ 212 198 214 219 
  Gross energy (mJ/kg) 21.5 21.1 21.8 21.0 
  Digestible energy (mJ/kg) 18.9 18.4 19.8 18.6 
a Ridley aquafeeds, Narangba, QLD, Australia. Fish meal defatted with hexane (see methods) 
b Manildra Group, Rocklea, QLD, Australia. 
c Bulk Powders, Moorabbin, Victoria, Australia. 
d Vitamin and mineral premix (g/kg of premix): vitamin A, 0.75 mg; vitamin D3, 6.3 mg; vitamin E, 16.7 g; 
vitamin K3, 1.7 g; vitamin B1, 2.5 g; vitamin B2, 4.2 g; vitamin B3, 25 g; vitamin B5, 8.3 g; vitamin B6, 2.0 
g; vitamin B9, 0.8 g; vitamin B12, 0.005 g; biotin, 0.17 g; vitamin C, 75 g; choline, 166.7 g; inositol, 58.3 g; 
ethoxyquin, 20.8 g; copper, 2.5 g; ferrous iron, 10.0 g; magnesium, 16.6 g; manganese, 15.0 g; zinc, 25.0 g. 
e Yttrium oxide; Stanford Materials, Aliso Viejo, California, United States. 
f Swisse, Collingwood, Victoria, Australia. 
g Sydney Essential Oil Co. Sydney, NSW, Australia. 
^ Calculated by difference.  
Table 3 Neutral and polar lipid composition of experimental diets, all values are mg/g 
lipid unless otherwise stated  
    Diets       
 
  
n-3 NL 
(Fish) 
n-3 PL 
(Krill) 
n-6 NL 
(Soybean) 
n-6 PL 
(Lecithin) 
Lipid class (% total lipid)         
  Neutral 91.5 67.5 89.7 51.1 
  Polar 8.5 32.5 10.3 48.9 
Neutral lipid fatty acids ^         
 
16:0 190.9 186.7 137.7 207.6 
  18:0 45.9 34.0 44.0 52.3 
  18:1n-9 194.6 223.6 252.9 225.4 
  18:2n-6 48.0 69.7 351.5 183.5 
  18:3n-3 10.2 10.8 40.3 22.2 
  20:4n-6 10.9 5.6 0.0 6.2 
  20:5n-3 79.4 92.6 13.1 35.0 
  22:5n-3 14.4 5.0 3.6 7.3 
  22:6n-3 117.5 71.8 19.7 54.7 
  SFA  298.6 304.0 195.1 291.5 
  MUFA  284.0 293.1 274.7 278.4 
  C18PUFA 58.3 97.7 395.7 210.9 
  LC-PUFA 222.2 175.1 36.4 103.3 
  Total n-3  211.2 186.7 40.2 102.3 
  Total n-6  69.2 86.1 391.9 211.9 
  Total fatty acids 863.1 869.9 901.8 884.0 
Polar lipid fatty acids ^         
 
16:0 139.5 147.3 121.4 118.7 
  18:0 44.1 18.4 35.9 27.7 
  18:1n-9 101.8 87.0 109.0 68.1 
  18:2n-6 121.4 55.3 150.9 317.6 
  18:3n-3 7.7 7.0 11.6 37.3 
  20:4n-6 10.1 ND 6.9 ND 
  20:5n-3 27.5 87.8 29.3 5.9 
  22:5n-3 7.4 4.4 4.9 ND 
  22:6n-3 60.0 68.2 41.6 12.1 
  SFA  204.8 188.9 166.1 146.4 
  MUFA  144.9 110.4 128.5 71.6 
  C18PUFA 129.1 71.6 162.5 354.9 
  LC-PUFA 105.0 160.4 82.6 18.0 
  Total n-3  94.9 169.7 75.7 18.0 
  Total n-6  139.2 62.3 169.4 354.9 
  Total fatty acids 583.8 531.2 539.7 591.0 
n-3 NL, Fish oil; n-3 PL, Krill oil; n-6 NL, Soybean oil; n-6 PL, Soybean lecithin. 
ND, not detected. 
^ Refer to Table 1 for details.  
 
  
   
Table 4 Real time quantitative PCR primer pairs for fatty acid metabolism and control genes. 
Target name Abbreviation EC number Primer name Sequence Length 
 
Fatty acid synthase Lc FAS EC 2.3.1.85 FAS qPCR.For1 TGAATCTCACCACGCTTCAG 20 
 
   
FAS qPCR.Rev1 AGGCAGCAATAGAACCCTCA 20 
 
Steroyl CoA desaturase Lc SCD EC 1.14.19.1 SCD qPCR.For1 CCTGGTACTTCTGGGGTGAA 20 
 
   
SCD qPCR.Rev1 AAGGGGAATGTGTGGTGGTA 20 
 
Carnitine palmitoyltransferase Lc CPT1α EC 2.3.2.21 CPT1a qPCR.For1 TGATGGTTATGGGGTGTCCT 20 
 
   
CPT1a qPCR.Rev1 CGGCTCTCTTCAACTTTGCT 20 
 
ATP citrate lyase Lc ACYL EC 2.3.3.8 Lcal acyl F1 CAACACCATTGTCTGTGCTC 20 
 
   
Lcal acyl R1 GAAATGCTGCTTAACAAAGTCC 21 
 
Fatty acid elongation 5 Lc ELOVL5 EC 2.3.1.n8 Lcal Fads2 F1 ATCCAGTTCTTCTTAACCGT 20 
 
   
Lcal Fads2 R1 GGTTTCTCAAATGTCAATCCAC 22 
 
Fatty acid desaturase 6 Lc FADS2 EC 1.14.19 Lcal ELOVL5 F1 TCATACTACCTTCGCTACTTCTC 23 
 
   
Lcal ELOVL5 R1 ACAAACCAGTGACTCTCCAG 20 
 
Luciferase Luc NA Luc qPCR For GGTGTTGGGCGCGTTATTTA 20 
 
   
Luc qPCR Rev CGGTAGGCTGCGAAATGC 18 
 
Elongation factor 1α EF1α NA Lcal EF1a F AAATTGGCGGTATTGGAAC 19 
 
   
Lcal EF1a R GGGAGCAAAGGTGACGAC 18 
 
NA, Not analysed. 
  
 
   
n-3 NL; Fish oil, n-3 PL; Krill oil, n-6 NL; Soybean oil, n-6 PL; Soybean lecithin; Ret. nutrient = (nutrient final - nutrient initial / nutrient consumed) * 100.  
‘ * ’ < 0.05, ‘ ** ’ < 0.01, ‘ *** ’ < 0.001; superscript letters indicate significant differences among means. 
† Two-way factorial ANOVA, df 1,1,1,8, post-hoc Tukey's HSD; Elongation analysed by one-way ANOVA, df 2,6, post-hoc Tukey’s HSD. 
NS, not significant P > 0.05.  
Table 5 Growth and feed utilisation parameters of juvenile barramundi fed experimental diets for eight weeks. Data (n=3) are presented as mean ± SEM. 
  Diets       Test †       
  
n-3 NL  
(Fish) 
n-3 PL  
(Krill) 
n-6 NL  
(Soy) 
n-6 PL  
(Lecithin) Omega Class Interaction   
Initial weight (g) 46.9 ± 0.1 46.7 ± 0.2 47.1 ± 0.1 46.9 ± 0.2 NS NS NS   
Final weight (g) 238.3 ± 1.2 a 237.1 ± 1.1 a 217.5 ± 1.6 b 233.4 ± 3.8 a *** * **   
Feed intake 209.6 ± 2.7 b 211.1 ± 2.6 b 189.4 ± 0.7 c 222.2 ± 0.9 a * *** ***   
FCR 1.10 ± 0.1 a 1.11 ± 0.1 a 1.11 ± 0.1 a 1.19 ± 0.1 b * * *   
Survival (%) 98.0 98.0 100.0 98.0 NS NS NS   
Ret. Protein (%) 34.1 ± 1.1 34.1 ± 1.5 31.7 ± 0.9 28.4 ± 0.5 NS NS NS   
Ret. lipid (%) 48.6 ± 4.5 49.8 ± 1.4 49.2 ± 1.4 43.1 ± 3.6 NS NS NS   
Table 6 Apparent digestibility (%) parameters of the diets fed to juvenile barramundi. Data (n=3) are presented as mean ± SEM 
   Diets       Test †     
 
  
n-3 NL  
(Fish) 
n-3 PL  
(Krill) 
n-6 NL 
(Soybean) 
n-6 PL 
(Lecithin) Omega Class Interaction 
Diet 
 Dry matter 64.3 ± 1.6 67.4 ± 1.6 63.7 ± 4.1 66.6 ± 2.2 NS NS NS 
 Protein 91.1 ± 0.7 91.2 ± 1.8 92.6 ± 0.3 92.8 ± 0.4 NS NS NS 
 Lipid 90.7 ± 0.9 ab 91.2 ± 1.2 ab 94.2 ± 0.4 a 89.3 ± 0.6 b NS * * 
 Energy 87.3 ± 1.5 86.6 ± 1.3 89.3 ± 0.7 87.5 ± 0.8 NS NS NS 
Fatty acids ^ 
 16:0 81.5 ± 1.9 a 84.2 ± 1.0 ab 87.7 ± 0.8 b 84.4 ± 0.8 ab * NS * 
 18:0 76.7 ± 3.0 77.5 ± 2.9 84.6 ± 1.2 79.5 ± 1.1 NS NS NS 
 18:1n-9 92.1 ± 0.8 90.4 ± 2.7 95.0 ± 0.3 90.5 ± 0.4 NS NS NS 
 18:2n-6 95.8 ± 0.2 ab 94.9 ± 1.0 ab 97.3 ± 0.1 a 90.3 ± 1.6 b NS ** * 
 18:3n-3 98.6 ± 1.2 a 100.0 ± 0.0 98.3 ± 0.1 a 92.5 ± 1.4 b NA NA NA 
 20:4n-6 100.0 ± 0.0 100.0 ± 0.0 100.0 ± 0.0 100.0 ± 0.0 NA NA NA 
 20:5n-3 99.0 ± 0.4 97.7 ± 0.2 100.0 ± 0.0 100.0 ± 0.0 NA NA NA 
 22:5n-3 100.0 ± 0.0 100.0 ± 0.0 100.0 ± 0.0 100.0 ± 0.0 NA NA NA 
 22:6n-3 98.5 ± 0.2 96.0 ± 0.2 92.9 ± 0.6 98.0 ± 2.0 NS NS NS 
 SFA 82.3 ± 1.8 85.3 ± 1.1 87.3 ± 1.0 84.1 ± 0.6 NS NS NS 
 MUFA 92.6 ± 0.8 91.3 ± 2.3 94.7 ± 0.4 91.1 ± 0.4 NS NS NS 
 C18PUFA 96.5 ± 0.2 a 96.1 ± 0.7 a 97.5 ± 0.1 a 90.5 ± 1.5 b * ** * 
 LC-PUFA 98.9 ± 0.2 97.1 ± 0.2 96.2 ± 0.3 98.9 ± 1.1 NS NS NS 
 Total n-3 98.9 ± 0.2 97.5 ± 0.1 97.6 ± 0.1 95.2 ± 1.5 NS NS NS 
 Total n-6 96.3 ± 0.1 a 95.2 ± 0.9 ab 97.2 ± 0.1 a 91.1 ± 1.4 b NS ** * 
‘ * ’ < 0.05, ‘ ** ’ < 0.01, ‘ *** ’ < 0.001; superscript letters indicate significant differences among means. 
† Two-way factorial ANOVA, df 1,1,1,8, post-hoc Tukey's HSD; 18:3n-3 analysed by one-way ANOVA df 3,7, P<0.01, post-hoc Tukey's HSD. 
NA, not analysed; NS, not significant P > 0.05. 
^ Refer to Table 1 for details.  
  
Table 7 Neutral and polar lipid composition in the whole body of juvenile barramundi fed experimental diets. All values are mg/g lipid unless 
otherwise stated. Data (n=3) are presented as mean ± SEM. 
  
 
Diets       Test †     
    
n-3 NL  
(Fish) 
n-3 PL  
(Krill) 
n-6 NL  
(Soybean) 
n-6 PL  
(Lecithin) Omega Class Interaction 
Lipid class (% total lipid) 
         Neutral 91.7 ± 1.1 91.4 ± 1.4 94.0 ± 1.5 89.4 ± 0.6 NS NS NS 
  Polar 8.3 ± 1.1 8.6 ± 1.4 6.0 ± 1.5 10.6 ± 0.6 NS NS NS 
Neutral lipid fatty acids ^ 
       
 
16:0 227.1 ± 2.1 a 229.6 ± 1.1 a 198.0 ± 4.5 b 238.4 ± 3.9 a * *** *** 
  18:0 61.2 ± 0.6 ab 56.5 ± 0.7 a 64.6 ± 1.9 b 71.3 ± 0.9 c *** NS ** 
  18:1n-9 254.8 ± 3.3 a 257.1 ±0.6 a 286.7 ±8.0 b 244.1 ± 1.6 a NS ** *** 
  18:2n-6 76.4 ± 1.6 a 82.5 ± 0.8 a 264.5 ± 8.9 b 202.0 ± 0.4 c *** *** *** 
  18:3n-3 9.0 ± 0.3 a 10.0 ± 0.1 a 27.0 ± 1.2 b 21.2 ± 0.2 c *** ** *** 
  20:4n-6 5.6 ± 0.1 1.2 ± 1.2 ND ND NA NA NA 
  20:5n-3 32.1 ± 0.9 a 53.2 ± 1.1 b 8.7 ± 0.7 c 10.5 ± 0.2 c *** *** *** 
  22:5n-3 13.4 ± 0.4 a 11.6 ± 0.2 b 5.9 ± 0.3 c 6.5 ± 0.1 c *** NS ** 
  22:6n-3 54.7 ± 2.4 a 47.4 ± 1.4 b 18.0 ± 1.1 c 21.1 ± 0.7 c *** NS ** 
  SFA  335.3 ± 1.8 a 331.4 ± 0.8 a 286.7 ± 7.0 b 338.3 ± 4.7 a ** *** *** 
  MUFA  322.9 ± 3.9 a 315.3 ± 0.6 a 319.1 ± 8.3 a 284.7 ± 2.0 b ** ** * 
  C18PUFA 97.7 ± 1.8 a 109.7 ± 0.8 a 297.4 ± 10.0 c 231.3 ± 0.3 b *** *** *** 
  LC-PUFA 105.8 ± 3.8 a 113.3 ± 3.0 a 37.5 ± 2.3 b 43.1 ± 1.0 b *** * NS 
  Total n-3  106.4 ± 3.9 b 123.1 ± 2.7 a 32.5 ± 2.1 c 38.1 ± 0.9 c *** ** NS 
  Total n-6  97.0 ± 1.7 a 99.9 ± 1.9 a 302.3 ± 10.2 c 236.2 ± 0.3 b *** *** *** 
  Total fatty acids 861.6 ± 5.7 a 869.7 ± 3.8 a 940.7 ± 25.6 b 897.3 ± 5.4 ab ** NS NS 
Polar lipid fatty acids ^ 
       
 
16:0 171.4 ± 5.7 a 163.6 ± 0.2 a 135.8 ± 2.4 b 143.8 ± 2.8 b ** NS NS 
  18:0 65.9 ± 4.5 62.0 ± 1.2 69.9 ± 0.6 61.7 ± 3.5 NS NS NS 
  18:1n-9 155.0 ±1.0 145.2 ± 3.4 139.1 ± 4.5 143.3 ± 8.9 NS NS NS 
  18:2n-6 42.9 ± 0.9 a 39.5 ± 1.7 a 129.7 ± 3.2 b 120.3 ± 9.9 b *** NS NS 
  18:3n-3 ND ND ND 9.8 ± 1.6 NA NA NA 
  20:4n-6 12.2 ± 2.6 6.9 ± 1.3 8.9 ± 0.1 5.7 ± 0.5 NS NS NS 
  20:5n-3 26.5 ± 3.2 ab 35.2 ± 5.4 a 11.1 ± 0.1 b 11.4 ± 0.7 b ** NS NS 
  22:5n-3 11.8 ± 1.6 10.8 ± 1.8 10.0 ± 0.3 7.0 ± 0.1 NS NS NS 
  22:6n-3 66.8 ± 13.0 a 57.6 ± 11.9 a 42.1 ± 0.9 ab 24.5 ± 1.7 b * NS NS 
  SFA  254.9 ± 6.4 a 244.9 ± 3.2 ab 205.7 ± 3.0 c 221.2 ± 5.3 bc ** NS NS 
  MUFA  189.9 ± 6.0 175.7 ± 6.3 156.5 ± 4.8 172.7 ± 8.3 NS NS NS 
  C18PUFA 48.4 ± 3.6 a 43.2 ± 4.7 a 133.3 ± 6.1 b 135.0 ± 12.2 b *** NS NS 
  LC-PUFA 117.3 ± 20.4 a 110.5 ± 20.4 a 83.9 ± 1.4 ab 56.0 ± 1.8 b * NS NS 
  Total n-3  106.7 ± 16.4 a 100.4 ± 17.7 a 63.2 ± 1.3 ab 42.9 ± 1.1 b * NS NS 
  Total n-6  59.0 ± 0.3 a 48.3 ± 2.0 a 154.1 ± 6.0 b 148.1 ± 11.5 b *** NS NS 
  Total fatty acids 610.6  ± 17.2 569.4 ± 6.1 579.4 ± 12.5 584.8 ± 13.4 NS NS NS 
‘ * ’ < 0.05, ‘ ** ’ < 0.01, ‘ *** ’ < 0.001; superscript letters indicate significant differences among means. 
† Two-way factorial ANOVA, df 1,1,1,8, post-hoc Tukey's HSD 
NA, not analysed; ND, not detected; NS, not significant P > 0.05. 
^ Refer to Table 1 for details.  
Table 8 Whole body fatty acid balance calculations of β-oxidation, elongation and desaturation of juvenile barramundi fed experimental diets for eight weeks. 
All values are presented as nmol/g fish/d. Data (n=3) are presented as mean ± SEM.  
  
 
Diets 
 
Test †   
  
n-3 NL  
(Fish) 
n-3 PL  
(Krill) 
n-6 NL  
(Soybean) 
n-6 PL  
(Lecithin) Omega Class Interaction 
β-Oxidation ^ 
 
SFA 339.7 ± 18.2 ND ND 45.7 ± 0.3 NA NA NA 
 
MUFA 554.1 ± 43.9b 120.4 ± 5.7c 8.1 ± 6.1c 1338.2 ± 113.2a *** *** *** 
 
C18PUFA 661.6 ± 34.9b 411.9 ± 22.9bc 46.5 ± 1.5c 3376.6 ± 208.4a *** *** *** 
  LC-PUFA 1695.1 ± 102.7a 1049.5 ± 53.3b 171.5 ± 5.9c 136.9 ± 22.8c *** *** *** 
 
Total n-3 1688.5 ± 103.5a 1101.8 ± 56.7b 125.2 ± 5.8c 116.7 ± 20.9c *** ** ** 
  Total n-6 668.1 ± 34.3b 359.5 ± 19.9bc 92.8 ± 1.8c 3396.9 ± 209.2a *** *** *** 
Elongation ^ 
 
SFA 73.0 ± 10.1d 3154.3 ± 297.9b 4894.0 ± 205.1a  1301.4 ± 438.2c *** NS *** 
 
MUFA ND ND 17.8 ± 3.5 ND NA NA NA 
 
C18PUFA ND ND ND ND NA NA NA 
  LC-PUFA ND 118.5 ± 7.1a 55.4 ± 1.0b 65.1 ± 2.9b NA NA NA 
 
Total n-3 ND 118.5 ± 7.1a 55.4 ± 1.0b 65.1 ± 2.9b NA NA NA 
  Total n-6 ND ND ND ND NA NA NA 
Desaturation 
 
SCD (Δ-9 Des.) 2.4 ± 2.4c 466.7 ± 60.9b 1138.0 ± 41.2a 19.2 ± 14.0c ** *** *** 
 
FADS2 (Δ-6 Des.) ND ND 29.1 ± 1.2 40.1 ± 1.6 NA NA NA 
SCD, Steroyl CoA desaturase; FADS2, Fatty acid desaturase 6. FADS1 (Δ-5 Des.) and chain shortening were not detected or reported. 
‘ * ’ < 0.05, ‘ ** ’ < 0.01, ‘ *** ’ < 0.001; superscript letters indicate significant differences among means. 
† Two-way factorial ANOVA, df 1,1,1,8, post-hoc Tukey's HSD; Elongation LC-PUFA and total n-3 were analysed by one-way ANOVA df 3,7, post-hoc 
Tukey's HSD. NA, not analysed; ND, not detected; NS, not significant P > 0.05. 
^ Refer to Table 1 for details. 
 
  
Table 9 Plasma chemistry of barramundi fed experimental diets for eight weeks. Data (n=3) are presented as mean ± SEM. 
  Diets       Test †     
  
n-3 NL  
(Fish) 
n-3 PL  
(Krill) 
n-6 NL  
(Soybean) 
n-6 PL  
(Lecithin) Omega Class Interaction 
CK (U/L) 7486.3 ± 3156.8 3394.0 ± 1048.1 3667.7 ± 631.9 3591.0 ± 1076.3 NS NS NS 
ALT (U/L) 8.7 ± 4.3 4.3 ± 1.5 5.7 ± 4.3 9.0 ± 3.9 NS NS NS 
GLDH (U/L) 10.0  ± 2.6 a 9.3 ± 6.5 a 11.3 ± 3.0 a 24.7 ± 8.3 b *** *** *** 
Urea (mmol/L) 2.9 ± 0.6 2.2 ± 0.4 3.1 ± 0.5 3.0 ± 0.3 NS NS NS 
Creatinine (umol/L) 22.7 ± 0.3 a 23.3 ± 1.1 a 21.7 ± 1.0 a 28.0 ± 1.2 b * *** ** 
Ca (mmol/L) 3.2 ± 0.1 3.0 ± 0.2 3.3 ± 0.2 3.3 ± 0.1 NS NS NS 
Mg (mmol/L) 1.8 ± 0.2 1.4 ± 0.6 1.6 ± 0.2 1.7 ± 0.3 NS NS NS 
Phosphate (mmol/L) 3.6 ± 0.2 3.3 ± 0.2 3.7 ± 0.4 4.0 ± 0.3 NS NS NS 
Cholesterol (mmol/L) 5.6 ± 0.3 ab 6.8 ± 0.2 a 4.4 ± 0.6 b 4.4 ± 0.3 b *** * * 
Total Protein (g/L) 48.1 ± 1.2 a 49.9 ± 2.8 ab 48.1 ± 0.9 a 54.3 ± 0.8 b NS ** NS 
Albumin (g/L) 13.6 ± 0.5 13.8 ± 0.9 14.1 ± 0.4 16.0 ± 0.4 NS NS NS 
Fe (umol/L) 21.5 ± 0.7 21.7 ± 1.0 19.6 ± 2.6 27.1 ± 2.6 NS NS NS 
Hb (mg/ml) 0.26 ± 0.5 b 0.10 ± 0.1 a 0.07 ± 0.7 a 0.14 ± 0.9 ab NS NS ** 
Haptoglobin (mg/ml) 1.3 ± 0.1 a 1.3 ± 0.1 a 1.3 ± 0.1 ab 1.4 ± 0.1 b ** NS NS 
CK, creatine kinase; ALT, alanine aminotransferase; GLDH, glutamate dehydrogenase.  
‘ * ’ < 0.05, ‘ ** ’ < 0.01, ‘ *** ’ < 0.001; superscript letters indicate significant differences among means. 
† Two-way factorial ANOVA, df 1,1,1,8, post-hoc Tukey's HSD 
NS, not significant P > 0.05. 
 
  
Figure 1 
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